News

14.10.2019

Pathogen Detection in Perianal Streptococcal Dermatitis

ArcDia International Ltd is pleased to announce that perianal streptococcal dermatitis has been added as...

7.10.2019

Mr. Vesa Kemppainen appointed as the new CEO

Mr. Vesa Kemppainen has been appointed as the CEO of ArcDia International Ltd as of...

9.4.2019

ArcDia has entered into an exclusive license agreement with Xinhua Healthcare for the commercialisation of ArcDia’s mariPOC® technology in China

Turku, 9th April 2019 – Today, ArcDia International Oy Ltd, manufacturer of the successful mariPOC®...

24.5.2018

mariPOC® ensures lower probability for C. difficile misdiagnosis with precision

mariPOC® ensures lower probability for C. difficile misdiagnosis with precision mariPOC® CDI test is a...

8.2.2018

New research data shows that influenza antigen testing correlates best with the infectivity period

A recent study by Inagaki et al. in The Journal of Infectious Diseases shows that,...

1.11.2017

Press release: New test for detection of C. difficile infection

Turku Finland, 11/1/2017 – Today, the Finnish medical device manufacturer ArcDia International Ltd launches a new IVD test...

2.8.2017

New QuickStrepA

ArcDia has updated the mariPOC® test for tonsillitis. The new QuickStrepA test reports final result already in 15 min. The...

6.4.2017

Study: Diagnosis of respiratory tract infections caused by human bocavirus 1

Human bocavirus 1 (HBoV1) causes respiratory tract infections in infants and children. Diagnosis of acute...

7.3.2017

New mariPOC influenza A virus test with significantly improved sensitivity

mariPOC® is present in Virology Days in Jyväskylä 14-15.3.2017. Petri Antikainen from ArcDia gives an...

21.12.2016

New test for Flu A

The influenza A virus test of mariPOC® respi has been updated. It is now 10-30%...

8.6.2016

World’s fastest antibiotic resistance testing

ArcDia’s groundbreaking technology enables world’s fastest phenotypic antibiotic resistance testing Turku, June 8, 2016 –...

28.4.2016

New mariPOC® Gastro test available

ArcDia International Oy Ltd. has launched a new product line for rapid diagnostics of acute...

17.3.2016

Detection and monitoring of human bocavirus 1 infection by a new rapid antigen test

Clinically relevant diagnosis of human bocavirus 1 (HBoV1) is challenging, as the virus is frequently...

2.2.2016

ArcDia contributes solving the global problem of antimicrobial resistance

mariPOC by ArcDia is taking part in the Longitud Prize competition which aims to develop...

9.12.2015

Press release: Spanish clinical study demonstrates mariPOC’s excellent performance

A recent study demonstrates that treatment of influenza-like illnesses can be significantly improved by using...

1.9.2015

ArcDia is developing pandemics preparedness

ArcDia has signed an agreement to develop diagnostic system to increse pandemic preparedness. The R&D...

11.5.2015

The diagnostics of group A streptococcus from pharyngeal swab samples by bacterial culture is challenged by a novel mariPOC point of care test.

Journal of Clinical Microbiology has published the study about point of care testing of group...

31.10.2014

The Flu Season Has Begun – mariPOC® Helps

Flu is one of the most common reasons for sick leaves from work, school or...

9.10.2014

Nobel Prize awarded to mariPOC® sister technology

The year 2014 Nobel Prize in Chemistry has been awarded to a Professor Stefan W....

3.10.2014

The Evolution of Rapid POC Tests for Infectious Disease Diagnostics: An Exclusive SelectScience Interview

Earlier this year, Frost & Sullivan, the global research organization, awarded ArcDia the European Respiratory...

9.4.2014

ArcDia Receives Frost & Sullivan Award for Point-of-Care Product Leadership!

Frost & Sullivan has recognized mariPOC® as the leading product in rapid diagnostics testing of...

24.1.2014

ArcDia launches world’s first antigen test for human bocavirus – Press Release

ArcDia launches world’s first antigen test for human bocavirus - Press Release pdf

24.9.2013

New press release

ArcDia has expanded its distributor and service network to cover 16 countries in Europe and...